MAIA · MAIA Biotechnology, Inc.
$1.24
+0.04 (+2.92%)
At close · Jul 30
Market Cap
$72.96M
Shares
60.80M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Vlad Vitoc | CEO | $2,084,632 |
| Sergei M. Gryaznov | Chief Scientific Officer | $1,267,294 |
| Jeffrey C. Himmelreich | Head of Finance | $420,988 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Vlad Vitoc | CEO | $1,360,441 |
| Sergei M. Gryaznov | Chief Scientific Officer | $929,838 |
| Jeffrey C. Himmelreich | Head of Finance | $338,374 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Vlad Vitoc | CEO | $1,386,240 |
| Sergei M. Gryaznov | Chief Scientific Officer | $852,721 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Vlad Vitoc | CEO | $1,207,770 |
| Mihail Obrocea | Chief Medical Officer | $851,494 |
| Sergei M. Gryaznov | Chief Scientific Officer | $770,879 |
| Joseph F. McGuire | CFO | $733,988 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mihail Obrocea | Chief Medical Officer | $2,145,986 |
| Joseph F. McGuire | CFO | $878,312 |
| Sergei M. Gryaznov | Chief Scientific Officer | $576,507 |